Exelon (EXC)

Investing Cash Flow

-$9.12B

TTM · Period ending: · USD

EXC logo

EXC Investing Cash Flow

Latest reported-$9.12B
EXC TTM Cash from Investing (-$588.90M → -$9.12B)
High-resolution chart · PNG

EXC investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Exelon Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-9,123,000,000
-8,939,000,000
-8,525,000,000
-8,028,000,000
-7,537,000,000
-7,217,000,000
-7,042,000,000
-6,974,000,000
-7,167,000,000
-7,271,000,000
-7,375,000,000
-7,519,000,000
-7,319,000,000
-7,042,000,000
-6,990,000,000
-6,092,000,000
-5,473,000,000
-5,231,000,000
-3,317,000,000
-3,435,000,000
-2,807,000,000
-2,166,000,000
-4,336,000,000
-5,157,000,000
-6,520,000,000
-7,549,000,000
-7,260,000,000
-7,440,000,000
-7,447,000,000
-7,763,000,000
-7,834,000,000
-7,733,000,000
-7,800,000,000
-7,380,000,000
-7,934,000,000
-8,094,000,000
-8,606,000,000
-9,366,000,000
-15,508,000,000
-15,357,000,000
-15,158,000,000
-14,624,000,000
-7,822,000,000
-6,912,000,000
-5,958,000,000
-5,339,000,000
-4,599,000,000
-4,797,000,000
-5,032,000,000
-4,934,000,000
-5,394,000,000
-5,224,000,000
-5,141,000,000
-5,424,000,000
-4,576,000,000
-3,897,000,000
-4,513,000,000
-4,047,000,000
-4,603,000,000
-5,888,000,000
-4,310,000,000
-4,364,000,000
-3,894,000,000
-3,111,000,000
-3,570,000,000
-3,415,000,000
-3,458,000,000
-3,285,000,000
-3,997,000,000
-3,025,000,000
-3,378,000,000
-3,321,000,000
-2,469,000,000
-3,355,000,000
-2,909,000,000
-2,841,000,000
-2,769,000,000
-3,185,000,000
-2,762,000,000
-2,745,000,000
-3,743,000,000
-2,157,000,000
-2,487,000,000
-2,286,000,000
-1,171,000,000
-1,929,000,000
-1,736,000,000
-1,986,000,000
-1,791,000,000
-2,025,000,000
-2,109,000,000
-2,042,000,000
-2,257,000,000
-2,358,000,000
-2,538,000,000
-2,606,000,000
-2,726,000,000
-2,488,000,000
-2,392,000,000
-2,193,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.